期刊文献+

细胞周期蛋白E与乳腺癌的内分泌治疗和预后

Cyclin E and its relationship with endocrine treatment and prognosis of breast cancer
原文传递
导出
摘要 细胞周期蛋白E(cyclin E)作为细胞进入S期的限速调节因子备受关注。研究表明,cyclin E与乳腺癌的内分泌治疗疗效和预后存在相关性,且与其他生物学指标相比,它与乳腺肿瘤预后的相关性更大。 Cyclin E is an important regulatory factor promoting cells to enter the S phase. Studies show that cyclin E has stronger correlation with the prognosis of breast cancer than other biomarkers and it is also correlated with curative effect of endocrine therapy of breast cancer.
出处 《国际肿瘤学杂志》 CAS 2009年第4期273-275,共3页 Journal of International Oncology
关键词 细胞周期蛋白E 乳腺肿瘤 治疗 预后 Cyclin E Breast neoplasms Therapy Prognosis
  • 相关文献

参考文献24

  • 1Sutherland RL, Musgrove EA. Cyclins and breast cancer. J Mammary Gland Biol Neoplasia, 2004, 9(1) :95-104.
  • 2Chappuis PO, Donato E, Coffin JR, et al. Cyclin E expression in breast cancer: predicting gerndine BRCA1 mutations, prognosis and response to treatment. Ann Oncol, 2005, 16(5) :735-742.
  • 3Harwell RM, Mull BB, Porter DC, et aL Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cells. J Biol Chem, 2004, 279(13) :12695- 12705.
  • 4Libertini SJ, Robinson BS, Dhillon NK, et al. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res, 2005, 65 ( 23 ) : 10700-10708.
  • 5Akli S, Zheng PJ, Muhani AS, et al. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res, 2004, 64 (9) :3198-3208.
  • 6Butt AJ, Caldon CE, McNeil CM, et al. Cell cycle machinery:links with genesis and treatment of breast cancer. Adv Exp Med Biol, 2008, 630 : 189-205.
  • 7Hunt KK, Keyomarsi K. Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol, 2005, 15 (4) :319- 326.
  • 8Wang L, Shao ZM. Cyclin E expression and prognosis in breast cancer patients: a meta-analysis of published studies. Cancer Invest, 2006, 24(6) :581-587.
  • 9Milano A, Dal Lago L, Sotiriou C, et al. What clinicians need to know about antioestrogen resistance in breast cancer therapy. Eur J Cancer, 2006, 42(16) :2692-2705.
  • 10Butt A J, McNeil CM, Musgrove EA, et al. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer, 2005, 12 Suppl 1 :S47-59.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部